COVID-19 and autoimmune diseases

Y Liu, AH Sawalha, Q Lu - Current opinion in rheumatology, 2021 - journals.lww.com
We present a review of the association between COVID-19 and autoimmune diseases,
focusing on similarities in immune responses, cross-reactivity of SARS-CoV-2, the …

Vaccine technologies and platforms for infectious diseases: Current progress, challenges, and opportunities

M Ghattas, G Dwivedi, M Lavertu, MG Alameh - Vaccines, 2021 - mdpi.com
Vaccination is a key component of public health policy with demonstrated cost-effective
benefits in protecting both human and animal populations. Vaccines can be manufactured …

Exploring Klebsiella pneumoniae capsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia

J Dey, SR Mahapatra, S Lata, S Patro… - Expert Review of …, 2022 - Taylor & Francis
Background Klebsiella pneumoniae is an emerging human pathogen causing neonatal lung
disease, catheter-associated infections, and nosocomial outbreaks with high fatality rates …

In silico design and immunoinformatics analysis of a universal multi-epitope vaccine against monkeypox virus

S Sanami, S Nazarian, S Ahmad, E Raeisi… - Plos one, 2023 - journals.plos.org
Monkeypox virus (MPXV) outbreaks have been reported in various countries worldwide;
however, there is no specific vaccine against MPXV. In this study, therefore, we employed …

In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives

MS Sohail, SF Ahmed, AA Quadeer… - Advanced drug delivery …, 2021 - Elsevier
Growing evidence suggests that T cells may play a critical role in combating severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, COVID-19 vaccines that can …

Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation

H Nguyen, HL Nguyen, PD Lan, NQ Thai… - Chemical Society …, 2023 - pubs.rsc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the devastating global COVID-19 pandemic announced by WHO in March 2020. Through …

In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics …

AA Omoniyi, SS Adebisi, SA Musa, JO Nzalak… - Scientific Reports, 2022 - nature.com
Abstract Crimean Congo Hemorrhagic Fever virus (CCHFV) is a deadly human pathogen
that causes an emerging zoonotic disease with a broad geographic spread, especially in …

Synthetic peptides that antagonize the angiotensin-converting enzyme-2 (ACE-2) interaction with SARS-CoV-2 receptor binding spike protein

A Sadremomtaz, ZM Al-Dahmani… - Journal of medicinal …, 2021 - ACS Publications
The SARS-CoV-2 viral spike protein S receptor-binding domain (S-RBD) binds ACE2 on
host cells to initiate molecular events, resulting in intracellular release of the viral genome …

Computationally optimized SARS-CoV-2 MHC class I and II vaccine formulations predicted to target human haplotype distributions

G Liu, B Carter, T Bricken, S Jain, M Viard… - Cell systems, 2020 - cell.com
We present a combinatorial machine learning method to evaluate and optimize peptide
vaccine formulations for SARS-CoV-2. Our approach optimizes the presentation likelihood of …

In silico design of a multi-epitope vaccine against HPV16/18

S Sanami, M Rafieian-Kopaei, KA Dehkordi… - BMC …, 2022 - Springer
Background Cervical cancer is the fourth most common cancer affecting women and is
caused by human Papillomavirus (HPV) infections that are sexually transmitted. There are …